Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 1.21 billion. The enterprise value is 1.35 billion.

Market Cap	1.21B
Enterprise Value	1.35B

Important Dates

The next estimated earnings date is Monday, March 3, 2025.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Exosens has 50.78 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	50.78M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	24.60%
Float	27.50M

Valuation Ratios

The trailing PE ratio is 621.01 and the forward PE ratio is 17.71. Exosens's PEG ratio is 0.77.

PE Ratio	621.01
Forward PE	17.71
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	136.34
P/FCF Ratio	27.94
P/OCF Ratio	n/a
PEG Ratio	0.77

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.02, with an EV/FCF ratio of 31.11.

EV / Earnings	691.33
EV / Sales	3.82
EV / EBITDA	15.02
EV / EBIT	21.06
EV / FCF	31.11

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.68.

Current Ratio	2.83
Quick Ratio	1.64
Debt / Equity	0.68
Debt / EBITDA	2.90
Debt / FCF	6.00
Interest Coverage	1.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	9.54%
Revenue Per Employee	221,074
Profits Per Employee	1,221
Employee Count	1,232
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20.98
200-Day Moving Average	n/a
Relative Strength Index (RSI)	67.47
Average Volume (20 Days)	50,541

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 353.72 million and earned 1.95 million in profits.

Revenue	353.72M
Gross Profit	202.00M
Operating Income	64.14M
Pretax Income	15.54M
Net Income	1.95M
EBITDA	87.44M
EBIT	64.14M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 123.20 million in cash and 260.60 million in debt, giving a net cash position of -137.40 million or -2.71 per share.

Cash & Cash Equivalents	123.20M
Total Debt	260.60M
Net Cash	-137.40M
Net Cash Per Share	-2.71
Equity (Book Value)	382.00M
Book Value Per Share	n/a
Working Capital	204.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.36 million and capital expenditures -30.94 million, giving a free cash flow of 43.43 million.

Operating Cash Flow	74.36M
Capital Expenditures	-30.94M
Free Cash Flow	43.43M
FCF Per Share	0.86

Full Cash Flow Statement

Margins

Gross margin is 57.11%, with operating and profit margins of 18.13% and 3.68%.

Gross Margin	57.11%
Operating Margin	18.13%
Pretax Margin	4.39%
Profit Margin	3.68%
EBITDA Margin	24.72%
EBIT Margin	18.13%
FCF Margin	12.28%

Dividends & Yields

Exosens does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.16%
FCF Yield	3.58%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 2.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.69
Piotroski F-Score	n/a